SCHEMBL7708442

SCHEMBL7708442

Nc1ncc(Oc2ccc(Cl)cc2)c(N2CCN(CCO)CC2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.45
ROCK2 O75116 2/20 0.43
ROCK1 Q13464 2/20 0.43
HPGD P15428 3/20 0.41
ALDH1A1 P00352 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
DHFR P00374 1/20 0.39
LTA4H P09960 1/20 0.39
PTGS2 P35354 1/20 0.39
MAPT P10636 2/20 0.39
TSHR P16473 2/20 0.39
HTT P42858 2/20 0.39
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HRH4 Q9H3N8 2/20 0.39
METAP1 P53582 1/20 0.39
GAA P10253 1/20 0.39
NR2F2 P24468 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714556 0.89 KMT2A (0.44) LMNAROCK2ROCK1ALDH1A1DHFR
SCHEMBL7714588 0.89 HTT (0.44) LMNAROCK2ROCK1ALDH1A1LTA4H
SCHEMBL7714141 0.89 SCN9A (0.47) LMNAROCK2ROCK1DHFRLTA4H
SCHEMBL7714186 0.89 KMT2A (0.48) LMNAROCK2ROCK1HPGDALDH1A1
SCHEMBL7714501 0.89 LMNA (0.46) LMNAROCK2ROCK1HPGDALDH1A1
SCHEMBL7708446 0.88 ROCK2 (0.41) LMNAROCK2ROCK1ALDH1A1DHFR
SCHEMBL7714708 0.88 LMNA (0.46) LMNAROCK2ROCK1HPGDALDH1A1
SCHEMBL7716574 0.87 KMT2A (0.53) LMNAROCK2ROCK1ALDH1A1DHFR
SCHEMBL7708594 0.87 ALDH1A1 (0.42) ROCK2ROCK1ALDH1A1HSD17B10MAPT
SCHEMBL7714398 0.86 KDM4E (0.43) LMNAHPGDALDH1A1PI4KBDHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed